NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Let me suggest to you that Direct is already used on what you probably consider operable cancer. Go to clinicaltrials.gov and see how they broadly define "inoperable." Now ask yourself, is there a biotherapeutic difference in treatment response to DCVAX-Direct based upon whether the tumor is "inoperable" or not? Having answered "no", take it one step further. When both are on the market, Which one would you pick to save your life?

Also, if it's insurance you are concerned about with multiple cancer type treatment with DCVAX-L, let me suggest to you that all of Europe, Japan, Great Britain and many other countries already have the equivalent to " Germany's 4b hospital exemption" statute, and the United States is contemplating this in the very near future -- albeit having to work it through a different regulated insurance system.